Reduction in nebulisation time of aqueous drug solutions by the eFlow rapid in comparison to a jet nebuliser to improve patient convenience and compliance Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005
Effect of device and formulation on delivery of budesonide suspensions by nebulizers Source: Eur Respir J 2002; 20: Suppl. 38, 542s Year: 2002
A breath-actuated jet nebulizer (BAN) has dosimetric capability for a suspension formulation based on differing volume fill of medication as well as run time Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010
Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation Source: Eur Respir J 2002; 20: Suppl. 38, 500s Year: 2002
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Bioequivalence of a new formulation of omalizumab, solution for injection in prefilled syringe, to the current lyophilized formulation Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
The mesh nebuliser: a recent technical innovation for aerosol delivery Source: ISSN=ISSN 1810-6838, ISBN=, page=252 Year: 2006
Evaluation of delivered dose and treatment time of several mesh nebulizers under in vitro simulated use Source: International Congress 2017 – Inhalers and their use Year: 2017
Estimation of efficiency of new combined preparation built-in-liposomes budesonide compared with water budesonide suspension Source: Eur Respir J 2004; 24: Suppl. 48, 83s Year: 2004
Evaluation of the technique of use of inhaler devices by patients at home through a video mobile application: A pilot study Source: International Congress 2019 – Clinical implications of asthma management Year: 2019
Reduction of nebulization time can be achieved with a new jet nebulizer design Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006
Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
Impact of critical handling errors on delivered budesonide/formoterol dose in dry powder inhalers – An in vitro study Source: International Congress 2016 – Pulmonary drug delivery Year: 2016
In vitro delivery of an HFA-based corticosteroid by pediatric and adult valved holding chambers (VHC): effect of inhalation flow rateSource: Eur Respir J 2002; 20: Suppl. 38, 500s Year: 2002
Validation and clinical application of a newly developed high-concentration oxygen-delivery device with a jet nebulizer function Source: Annual Congress 2010 - COPD: management Year: 2010
A preliminary assessment of the stability of 5-CF containing liposomes following aerosolisation with TouchSprayÔ technology and a commercial jet nebuliser Source: Eur Respir J 2003; 22: Suppl. 45, 471s Year: 2003
A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II Year: 2008
A novel submicron budesonide suspension demonstrates equivalent nebulization times compared to cyclodextrin-based solution formulations Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer. Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019
Aerosol delivery characteristics from a new jet nebulizer in comparison with commercially available jet nebulizers Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008